Por qué es un doctor de primer nivel

Dr Varun Mehra is a leading consultant haematologist based in London who specialises in myelodysplastic syndrome, acute leukaemia, autologous transplantation for autoimmune conditions such as multiple sclerosis, Crohn's disease, systemic sclerosis, allogeneic stem cell transplantation, immunotherapy and post transplant complications.

Dr Mehra completed his post-graduate specialist Haematology training at world renowned King's College Hospital, London, where he has been working for past few years as a core member of a busy Stem Cell Transplant & Cellular therapy unit, while pursuing his MD (res) Degree with King's College London University in developing novel diagnostic biomarkers for invasive fungal disease (aspergillosis) in immunocompromised Haemato-oncology patients. 

Dr Mehra has been instrumental in leading a large single centre NCRN badged prospective study on Invasive Fungal disease and has a good track record for his involvement in clinical trials, more recently as Chief and Principal Investigator of various clinical research studies in UK. He has developed key academic partnerships in mycology research and education within Kings Health Partners (KHP). He has published regularly on his disease specific research interests in high impact clinical and scientific journals.

Dr Mehra's main research interests are in infections of immunocompromised hosts, graft versus host disease and transplantation of autoimmune diseases; and have helped develop exciting research collaborations within and outside Kings Health Partners with bench to bed translation opportunities.

He also has strong interest in education and training. He chaired London School of Pathology Specialist Trainee Committee and represented London Pathology Trainees in the Royal College Specialist Advisory group between 2014-2016. He currently sits on the KHP Institute of Haematology Education & Training steering group, playing an active role in developing post-graduation modules for training in clinical haematology and other disease specific Preceptorship programs. Dr Mehra is also fully trained in the assessment of patients for, and delivery of CAR-T therapy, a highly specialised new therapy that has recently been licensed for certain patients with relapsed high grade B cell lymphomas and acute lymphoblastic leukaemia.

Especialidades

Myelodysplastic syndrome

...

Leukaemia

...

Bone marrow transplant

What is it?A bone marrow transplant is a therapeutic procedure that aims to replace damaged bone marrow with healthy marrow in order to treat ...

Lymphomas

What is lymphoma?Lymphoma is a group of blood cancers developing from lymphocytes, which are the cells that defend the body in the immune syst...

Myeloproliferative disorders

...

Low blood count

What is a low blood count?A low blood count means that you have fewer red or white blood cells or fewer platelets in your body than normal.&am...

Enfermedades, Pruebas y Tratamientos

Pide cita ahora

Contacto

  • King's College Hospital
    Denmark Hill SE5 9RS - London (Central London)
    (+44) 02076618824

¿Tienes alguna duda?
Nuestro equipo médico está encantado de atenderte

Valoraciones

Telemedicina

Es un servicio de mensajería privada y videoconferencia que te permite realizar una consulta médica conmigo en cualquier momento y lugar.

 

Vídeos

Artículos